does semaglutide cause nose bleeds Can GLP-1 Medications Be Considered for Weight Loss in Patients with APS? Patient Basics: Nosebleed (Epistaxis) |

Could these increased risks be mediated by changes in nutrient absorption or hormonal influences secondary to weight loss, and how might we mitigate these potential effects in clinical practice

Women with diabetes taking combined hormonal contraception face further elevated VTE risk, while those using hormone replacement therapy should note that transdermal formulations generally carry lower thrombotic risk than oral preparations

It increases insulin production to lower blood sugar

However, weight loss from Wegovy may improve the response to fertility medications later

This gentle approach prevents foaming, which creates air-liquid interfaces where peptides denature and aggregate irreversibly